Literature DB >> 24154599

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.

Amir Horowitz1, Dara M Strauss-Albee, Michael Leipold, Jessica Kubo, Neda Nemat-Gorgani, Ozge C Dogan, Cornelia L Dekker, Sally Mackey, Holden Maecker, Gary E Swan, Mark M Davis, Paul J Norman, Lisbeth A Guethlein, Manisha Desai, Peter Parham, Catherine A Blish.   

Abstract

Natural killer (NK) cells play critical roles in immune defense and reproduction, yet remain the most poorly understood major lymphocyte population. Because their activation is controlled by a variety of combinatorially expressed activating and inhibitory receptors, NK cell diversity and function are closely linked. To provide an unprecedented understanding of NK cell repertoire diversity, we used mass cytometry to simultaneously analyze 37 parameters, including 28 NK cell receptors, on peripheral blood NK cells from 5 sets of monozygotic twins and 12 unrelated donors of defined human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genotype. This analysis revealed a remarkable degree of NK cell diversity, with an estimated 6000 to 30,000 phenotypic populations within an individual and >100,000 phenotypes in the donor panel. Genetics largely determined inhibitory receptor expression, whereas activation receptor expression was heavily environmentally influenced. Therefore, NK cells may maintain self-tolerance through strictly regulated expression of inhibitory receptors while using adaptable expression patterns of activating and costimulatory receptors to respond to pathogens and tumors. These findings further suggest the possibility that discrete NK cell subpopulations could be harnessed for immunotherapeutic strategies in the settings of infection, reproduction, and transplantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154599      PMCID: PMC3918221          DOI: 10.1126/scitranslmed.3006702

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  51 in total

1.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes.

Authors:  Evan W Newell; Natalia Sigal; Sean C Bendall; Garry P Nolan; Mark M Davis
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 3.  Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.

Authors:  M Colonna
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

4.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

Authors:  Niklas K Björkström; Peggy Riese; Frank Heuts; Sandra Andersson; Cyril Fauriat; Martin A Ivarsson; Andreas T Björklund; Malin Flodström-Tullberg; Jakob Michaëlsson; Martin E Rottenberg; Carlos A Guzmán; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

5.  Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.

Authors:  Simona Sivori; Michela Falco; Lorenzo Moretta; Alessandro Moretta
Journal:  Trends Immunol       Date:  2010-07-12       Impact factor: 16.687

6.  Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity.

Authors:  J R Ortaldo; G D Bonnard; P D Kind; R B Herberman
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

7.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

8.  Application of CD27 as a marker for distinguishing human NK cell subsets.

Authors:  Anabel Silva; Daniel M Andrews; Andrew G Brooks; Mark J Smyth; Yoshihiro Hayakawa
Journal:  Int Immunol       Date:  2008-03-07       Impact factor: 4.823

9.  Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

Authors:  Pascale André; Roberta Castriconi; Marion Espéli; Nicolas Anfossi; Tiffany Juarez; Sophie Hue; Holli Conway; François Romagné; Alessandra Dondero; Marina Nanni; Sophie Caillat-Zucman; David H Raulet; Cristina Bottino; Eric Vivier; Alessandro Moretta; Pascale Paul
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

10.  Natural killer cells: from basic research to treatments.

Authors:  Eric Vivier; Sophie Ugolini
Journal:  Front Immunol       Date:  2011-06-03       Impact factor: 7.561

View more
  249 in total

1.  CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

Authors:  Bérengère Salomé; Alejandra Gomez-Cadena; Romain Loyon; Madeleine Suffiotti; Valentina Salvestrini; Tania Wyss; Giulia Vanoni; Dan Fu Ruan; Marianna Rossi; Alessandra Tozzo; Paolo Tentorio; Elena Bruni; Carsten Riether; Eva-Maria Jacobsen; Peter Jandus; Curdin Conrad; Manfred Hoenig; Ansgar Schulz; Katarzyna Michaud; Matteo Giovanni Della Porta; Silvia Salvatore; Ping-Chih Ho; David Gfeller; Adrian Ochsenbein; Domenico Mavilio; Antonio Curti; Emanuela Marcenaro; Alexander Steinle; Amir Horowitz; Pedro Romero; Sara Trabanelli; Camilla Jandus
Journal:  Blood Adv       Date:  2019-11-26

Review 2.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 3.  Systems immunology: just getting started.

Authors:  Mark M Davis; Cristina M Tato; David Furman
Journal:  Nat Immunol       Date:  2017-06-20       Impact factor: 25.606

4.  Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow.

Authors:  Mikael Roussel; P Brent Ferrell; Allison R Greenplate; Faustine Lhomme; Simon Le Gallou; Kirsten E Diggins; Douglas B Johnson; Jonathan M Irish
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

5.  Natural killer cells: a virtual pick and mix.

Authors:  Olive Leavy
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

Review 6.  Advancing systems immunology through data-driven statistical analysis.

Authors:  Linda E Fong; Andrés R Muñoz-Rojas; Kathryn Miller-Jensen
Journal:  Curr Opin Biotechnol       Date:  2018-04-12       Impact factor: 9.740

7.  Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Authors:  Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 8.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

9.  High-Dimensional Data Analysis Algorithms Yield Comparable Results for Mass Cytometry and Spectral Flow Cytometry Data.

Authors:  Laura Ferrer-Font; Johannes U Mayer; Samuel Old; Ian F Hermans; Jonathan Irish; Kylie M Price
Journal:  Cytometry A       Date:  2020-04-15       Impact factor: 4.355

10.  Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.

Authors:  Lisa M Kronstad; Christof Seiler; Rosemary Vergara; Susan P Holmes; Catherine A Blish
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.